#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypoxic-ischaemic encephalopathy Langerhans' cell histiocytosis Chemical burn Hypoparathyroidism Fibrosarcoma metastatic Cutaneous T-cell lymphoma stage II Neonatal asphyxia Barth syndrome Cutaneous T-cell lymphoma recurrent Diffuse large B-cell lymphoma recurrent Homocystinuria Pancreatic neuroendocrine tumour Arterial disorder Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Bulbospinal muscular atrophy congenital More trials…

    Learn about Rare Diseases

    Undifferentiated sarcoma – Diagnostics Malignant fibrous histiocytoma Skin angiosarcoma – Trials in Disease Gaucher’s disease type III – Life with Disease Mucopolysaccharidosis – Basic Information Familial amyotrophic lateral sclerosis – Treatment X-linked lymphoproliferative syndrome – Basic Information Netherton’s syndrome – Treatment Waldenstrom’s macroglobulinaemia recurrent – Trials in Disease Systemic sclerosis pulmonary – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Quinapril Hydrochloride Hct116-A Diltiazem Volixibat Cyclophosphamide Onfekafusp Alfa Bi 1015550 Lasmiditan Rhh646 Livmoniplimab Blu-451 STREPTOCOCCUS VIRIDANS Infliximab Transpocart19 Bisoprolol Entinostat ANUMIGILIMAB OMECAMTIV MECARBIL Df1001 Sar444656 More therapies…

    Learn about Your Condition

    Diabetes insipidus Urticaria Chondroplasty Dementia Alzheimer's type Stem cell transplant Fragile X syndrome Neurodevelopmental disorder Adenocarcinoma pancreas Varicella Morning sickness Psoriatic arthropathy Vulvovaginal pain Pulmonary resection Arteriosclerosis Carcinoid syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Anxiety

  • Comparison of Oxazepam 50 mg orodispersible tablets and Oxazepam 50 mg standard tablets in healthy volunteers to test if they work the same way in the body

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Anxiety
    Investigated Drugs:
    • Oxazepam
    Portugal

  • Study on the Bioequivalence of Oxazepam 10 mg Orodispersible Tablets Compared to Standard Tablets in Healthy Volunteers

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Anxiety
    Investigated Drugs:
    • Oxazepam
    Portugal

  • Title: Evaluation of nasal remimazolam and lidocaine for sedation and anxiety in adults: Testing comfort and effectiveness of nasal spray delivery

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Anxiety
    Investigated Drugs:
    • Remimazolam
    The Netherlands

  • Study on the Effects of Yohimbine and Hydrocortisone on Stress and Moral Decisions in Military Personnel

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Anxiety
    Investigated Drugs:
    • YOHIMBINE HYDROCHLORIDE
    • Cellulose, Microcrystalline
    • Hydrocortisone
    The Netherlands

  • Study on the Effects of Sertraline on Anxiety and Depression in Heart Failure Patients with Preserved Ejection Fraction

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Anxiety
    • Depression
    • Heart failure with preserved ejection fraction
    Investigated Drugs:
    • Sertraline
    Poland

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!